FDA approves test for emergency use in emerging avian influenza

04/25/2013 | GenomeWeb Daily News (free registration)

The CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel-Influenza A/H7 Assay has received an emergency use authorization from the FDA. The test, which will run on the Applied Biosystems 7500 Fast Dx Real-Time PCR platform, is intended to identify the presence of influenza A virus subtype H7N9 in patients exhibiting symptoms of respiratory infection. H7N9 is an avian strain of influenza that has surfaced in Asia, infecting more than 100 people. At least 20 patients have died.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC